8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Mar 7, 2024 · 2y ago · Accession 0001104659-24-031908
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Outlook Therapeutics, Inc.
- Ticker
- OTLK
- CIK
- 1649989
- Form type
- 8-K
- Filing date
- Mar 7, 2024
- Report date
- Mar 7, 2024
- Document
- tm248235d1_8k.htm
- Size
- 243 KB